Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,005 | 22 | 54.9% |
| Travel and Lodging | $8,154 | 46 | 20.4% |
| Compensation for serving as faculty or as a speaker for a medical education program | $4,000 | 3 | 10.0% |
| Consulting Fee | $3,269 | 4 | 8.2% |
| Food and Beverage | $2,247 | 33 | 5.6% |
| Education | $384.34 | 7 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AVEO Pharmaceuticals, Inc. | $25,468 | 66 | $0 (2023) |
| GENZYME CORPORATION | $13,554 | 33 | $0 (2023) |
| Exelixis Inc. | $443.64 | 11 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $354.00 | 1 | $0 (2021) |
| Astellas Pharma Global Development | $116.44 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $84.47 | 1 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $22.62 | 1 | $0 (2024) |
| PFIZER INC. | $15.20 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $355.00 | 8 | Astellas Pharma Global Development ($116.44) |
| 2023 | $8,015 | 26 | AVEO Pharmaceuticals, Inc. ($7,641) |
| 2022 | $27,843 | 71 | AVEO Pharmaceuticals, Inc. ($14,335) |
| 2021 | $3,846 | 10 | Aveo Pharmaceuticals, Inc. ($3,492) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Astellas Pharma Global Development | Padcev (Drug) | Food and Beverage | In-kind items and services | $116.44 | General |
| Category: Oncology | ||||||
| 12/17/2024 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 09/12/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 07/18/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Oncology | ||||||
| 04/24/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $41.98 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 03/07/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $32.98 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 02/28/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $84.47 | General |
| Category: Oncology | ||||||
| 12/18/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Travel and Lodging | Cash or cash equivalent | $321.06 | General |
| Category: Oncology | ||||||
| 12/18/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | Cash or cash equivalent | $79.05 | General |
| Category: Oncology | ||||||
| 12/12/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,700.00 | General |
| Category: Oncology | ||||||
| 12/07/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Travel and Lodging | In-kind items and services | $349.89 | General |
| Category: Oncology | ||||||
| 12/07/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Travel and Lodging | In-kind items and services | $119.60 | General |
| Category: Oncology | ||||||
| 12/07/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $67.87 | General |
| Category: Oncology | ||||||
| 12/05/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Travel and Lodging | Cash or cash equivalent | $214.84 | General |
| Category: Oncology | ||||||
| 12/05/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Travel and Lodging | Cash or cash equivalent | $41.13 | General |
| Category: Oncology | ||||||
| 12/05/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | Cash or cash equivalent | $15.27 | General |
| Category: Oncology | ||||||
| 12/05/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Travel and Lodging | Cash or cash equivalent | $5.00 | General |
| Category: Oncology | ||||||
| 11/29/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Oncology | ||||||
| 11/20/2023 | Exelixis Inc. | — | Education | In-kind items and services | $41.20 | General |
| 11/15/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,300.00 | General |
| Category: Oncology | ||||||
| 11/15/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $123.98 | General |
| Category: Oncology | ||||||
| 11/09/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Travel and Lodging | In-kind items and services | $198.24 | General |
| Category: Oncology | ||||||
| 11/09/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $94.58 | General |
| Category: Oncology | ||||||
| 08/10/2023 | Exelixis Inc. | — | Education | In-kind items and services | $44.97 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 279 | 726 | $127,980 | $45,159 |
| 2022 | 1 | 268 | 671 | $113,533 | $41,867 |
| 2021 | 1 | 227 | 597 | $92,001 | $38,337 |
| 2020 | 2 | 274 | 554 | $79,262 | $27,033 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 262 | 708 | $125,775 | $44,343 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 17 | 18 | $2,205 | $816.30 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 249 | 652 | $110,341 | $40,606 | 36.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 19 | $3,192 | $1,261 | 39.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 227 | 597 | $92,001 | $38,337 | 41.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 194 | 454 | $69,462 | $24,649 | 35.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 80 | 100 | $9,800 | $2,383 | 24.3% |
About Ghazal Jameel
Ghazal Jameel is a Nurse Practitioner healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/09/2013. The National Provider Identifier (NPI) number assigned to this provider is 1902237548.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ghazal Jameel has received a total of $40,059 in payments from pharmaceutical and medical device companies, with $355.00 received in 2024. These payments were reported across 115 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($22,005).
As a Medicare-enrolled provider, Jameel has provided services to 1,048 Medicare beneficiaries, totaling 2,548 services with total Medicare billing of $152,396. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Tampa, FL
- Active Since 12/09/2013
- Last Updated 03/25/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902237548
Products in Payments
- FOTIVDA (Drug) $25,468
- JEVTANA (Drug) $12,924
- Nubeqa (Drug) $354.00
- CABOMETYX (Drug) $143.80
- Padcev (Drug) $116.44
- LYNPARZA (Drug) $84.47
- ERLEADA (Drug) $22.62
- XTANDI (Drug) $15.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Tampa
April Wesson, Arnp, ARNP
Nurse Practitioner — Payments: $341,705
Sara Beeler, Aprn, APRN
Nurse Practitioner — Payments: $276,292
Lisa Nodzon, Arnp, ARNP
Nurse Practitioner — Payments: $228,971
Melissa Carver, Arnp, ARNP
Nurse Practitioner — Payments: $110,594
Sara Tinsley, Arnp, ARNP
Nurse Practitioner — Payments: $92,867
Ms. Jerrica Farias
Nurse Practitioner — Payments: $74,448